利益相反（ＣＯＩ）について研究内容を腸内細菌学会、および、腸内細菌学雑誌等に発表する際の基準とその申告および開示方法は以下の通りとする。

1. 利益相反（Conflict of Interest : COI）自己申告の基準
1) 当該研究に関連する一つの企業、あるいは、法人組織や営利を目的とした団体（以下、これらを営利団体という）からの役員、顧問の報酬額が 100 万円以上の場合。
2) 一つの企業の株式による利益（配当、売却益の総和）が 100 万円以上の場合。
3) 一つの営利団体からの特許使用料が 100 万円以上の場合。
4) 一つの営利団体からの講演料や原稿料が、それぞれ 50 万円以上の場合。
5) 一つの営利団体からの研究費（受託研究費や共同研究費、奨学寄付金など）が計 100 万円以上の場合。
6) 一つの営利団体が提供する寄付講座に所属している場合。
7) 一つの営利団体から研究とは直接関係の無い旅行や贈答品などを、計 5 万円以上受けた場合。

なお、上記の基準は年間あたりのものとする。

2. COI 開示方法
学会発表および論文発表に際し、筆頭者および研究責任者は、当該発表内容について COI 自己申告の基準に基づき、申告すべき COI 状態の有無を開示しなくてはならない。
1) 腸内細菌学会での発表
1-a) スライドを用いての口頭発表の際>①申告すべき COI 状態が無い場合
以下のようなスライドを発表スライドの 1 枚目に加える（例）。
COI 開示；腸内細菌学会
筆頭者氏名

○○ ○○

研究責任者

○○ ○○

当財団の規定に従い COI 開示をする。発表演題に関連し開示すべき事項は無い。

②申告すべき COI 状態がある場合

以下のようなスライドを発表スライドの 1 枚目に加える（例）。
COI 開示；腸内細菌学会
筆頭者氏名

○○ ○○

研究責任者

○○ ○○

当財団の規定に従い COI 開示をする。発表演題に関連し開示すべき事項を以下に示す（例）。

1． 役員・顧問：なし
2． 株保有状態：なし
3． 特許使用料：なし
4． 講演料・原稿料：なし
5． 受託研究費・共同研究費：あり（X X 食品）
6． 奨学寄付金：あり（ＹＹ製薬）
7． 寄付講座所属：なし

1-b) ポスター発表の際ポスターの最初もしくは最後に COI 開示として必要事項を記載する（上記参照）。

2) 腸内細菌学雑誌での発表
投稿規定に従い COI 開示として必要事項を記載する。

3.本規定における当財団関係者には会員外の発表者、投稿者が含まれるものとする。

The Intestinal Microbiology Society (IMS)
Conflict of Interest Regulations(Preamble)
Article 1
In compliance with the ethical rules of the Intestinal Microbiology Society (IMS), the councilors,
executive board members, auditors, members, officials, and related persons (hereafter referredto as persons related to our foundation) must disclose the facts about conflicts of interest withthis foundation if there is the possibility of their occurrence. These regulations stipulate the items
to be observed by persons related to our foundation in making presentations at the Annual
Meeting of the Intestinal Microbiology Society, etc., and contributing papers to the journals
published by our foundation.

(Conflict of Interest requirements and guidelines)
Article 2Persons related to our foundation are required to observe the following guidelines for selfreporting of conflict of interest:

1. Guidelines for self-reporting of conflict of interest (COI)1) Directors’ or advisors’ fees of ¥1,000,000 or more have been received from a businessfirm involved in the relevant research or a corporation or profit-oriented organization (theyare hereafter referred to as profit organizations).
2) A benefit (sum of dividends and gains on sale) of ¥1,000,000 or more has been received
from shares of stock of one business firm.
3) Royalties of ¥1,000,000 or more have been received from one profit organization.
4) Honoraria for lectures or manuscript fees of ¥500,000 or more each have been received

1

from one profit organization.
5) Research funds (research fee, co-research fee, grant donations, etc.) of a total of¥1,000,000 or more have been received from one profit organization.
6) The person related to our foundation belongs to an endowed chair provided by one profit
organization.
7) A total worth of ¥50,000 or more has been received from one profit organization in theforms of trips not directly related to research or gifts.

The above guidelines are applied on an annual basis.
2. COI guidelines
In making conference presentations or publishing papers, the first author and principalresearcher are required to report the presence or absence of COI to be disclosed according
to the COI self-reporting guidelines.
1) Presentation at the Annual Meeting of the IMS1-a) Oral presentation using slides① If there is no COI to disclose

Add the following slide (example) to the first slide of your presentation:
Disclosure of COI: Annual Meeting of The Intestinal
Microbiology Society (IMS)Name of first author:○○ ○○Principal researcher: ○○ ○○We disclose COI according to the IMS regulations. We have no COI to disclose associatedwith the presentation.
② If there is any COI to disclose2Add the following slide (example) to the first slide of your presentation:
Disclosure of COI: Annual Meeting of The Intestinal
Microbiology Society (IMS)Name of first author:○○ ○○Principal researcher: ○○ ○○We disclose COI according to the IMS regulations. Matters requiring disclosure of COI withregard to our presentation are as follows:[Example]

1．Directors’ or advisors’ fees: None
2．Stockholder: None
3．Royalties: None
4．Honoraria for lectures/Manuscript fees: None
5．Research fee/Co-research fee: Yes (XX food K.K.)
6．Grant donations: Yes (YY pharmaceutical Co., Ltd.)
7．Endowed chair: None1-b) Poster Presentations

COI statement is to be provided on the first/last page of the poster (see the example above)2) Publication in the Journal of Intestinal Microbiology
COI statement is to be provided according to the instructions for authors.

3. In this article, persons related to our foundation include non-member presenters andcontributors.
3

(Revision and Abolition)
Article 3 The revision or abolition of these Rules shall be determined by the meeting ofexecutive board members.

Supplementary ProvisionsThese regulations shall come into effect on July 1, 2015. (Approval obtained by the meeting ofexecutive board members on March 3, 2015)
These regulations were partially revised on July 15, 2021. (Resolution made by the 2nd meetingof executive board members)

4